Townsend T, Razanskaite V, Dodd S, Storey D, et al. Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease. Aliment Pharmacol Ther 2020;52:1341-1352.
PMID: 32955122